Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Michael E. DeBakey VA Medical Center - Houston, Texas

Veterans Crisis Line Badge
My HealtheVet badge
EBenefits Badge

Free Parkinson's Disease Patient & Family Forum

January 9, 2006



The Michael E. DeBakey Veterans Affairs Medical Center Parkinson's Disease Research, Education & Clinical Center (PADRECC) presents a free educational program and forum for veterans, family members, and friends: “Improving Care for Veterans with Parkinson's Disease.” Guest speakers include Eugene Lai, M.D., Ph.D., Gabriel Hou, M.D., Ph.D., and Aliya Sarwar, M.D.  A Question & Answer Session will follow.



Friday, January 13, 2006, 10 - 11:30 a.m.



4th Floor Auditorium
Michael E. DeBakey VA Medical Center
2002 Holcombe Blvd., Houston, Texas 77030
 Free valet parking is available.



For more information, please call Naomi Nelson, Ph.D., R.N. at (713) 794-8938.



The Department of Veterans Affairs (VA) took a major step toward improving patient care and pursuing a cure for Parkinson's disease by establishing six Parkinson's Disease Research, Education and Clinical Centers (PADRECCs), one at the Michael E. DeBakey VA Medical Center in Houston.

Operating as a national consortium, each PADRECC conducts research covering basic biomedicine, rehabilitation, health services delivery, and clinical trials.  Each is participating in a landmark clinical trial to assess the effectiveness of surgical implantation of deep brain stimulators in reducing the symptoms of Parkinson's disease.

The National Parkinson Foundation, Inc. estimates that up to 1.5 million Americans have Parkinson's disease and that approximately 50,000 new cases are diagnosed each year. VA medical centers treat at least 40,000 Parkinson’s disease patients every year.